Physician profile
Edward William Ference
NPI 1538692967
$1,467.03
in general payments reported to CMS, 2019-2025
7 companies · $76.92 in 2025
The $76.92 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $75.68 · 2021: $154 · 2022: $38.86 · 2023: $771 · 2024: $222 · 2025: $76.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $549 · Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $549.47 |
| Food and Beverage | $520.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $833.01 | 2023-2024 | Iovera, Zilretta |
| Merz North America, INC. | $203.93 | 2019-2020 | |
| Spr Therapeutics, INC | $195.69 | 2024-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $153.85 | 2021 | |
| Sanofi-Aventis U.S. LLC | $37.69 | 2022-2023 | |
| Abbott Laboratories | $22.33 | 2022 | |
| Boston Scientific Corporation | $20.53 | 2025 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Ference listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.